-
1دورية أكاديمية
المؤلفون: Ortega, Miguel A.Aff1, Aff2, Aff3, IDs00109024024633_cor1, Boaru, Diego Liviu, De Leon-Oliva, Diego, Fraile-Martinez, OscarAff1, Aff2, García-Montero, CieloAff1, Aff2, Rios, Laura, Garrido-Gil, Maria J., Barrena-Blázquez, SilvestraAff2, Aff4, Minaya-Bravo, Ana M.Aff1, Aff2, Rios-Parra, AntonioAff1, Aff2, Aff3, Álvarez-Mon, MelchorAff1, Aff2, Aff5, Jiménez-Álvarez, LauraAff1, Aff2, Aff6, López-González, LauraAff2, Aff6, Guijarro, Luis G.Aff1, Aff2, Diaz, RaulAff2, Aff6, Aff7, IDs00109024024633_cor15, Saez, Miguel A.Aff1, Aff2, Aff8
المصدر: Journal of Molecular Medicine. :1-14
-
2دورية أكاديمية
المؤلفون: Pedrero Prieto, ManuelAff1, IDs10072023072523_cor1, Gorriz Romero, DavidAff1, IDs10072023072523_cor2, Gómez Roch, Elisa, Pérez Miralles, Francisco-Carlos, Casanova Estruch, Bonaventura
المصدر: Neurological Sciences. 45(5):2199-2202
-
3دورية أكاديمية
المؤلفون: Park, Daniel, Jeon, Won, Yang, Chieh, Castillo, Dani
المصدر: Cancers. 16(2)
مصطلحات موضوعية: LAEC, immune checkpoint inhibitors (ICIs), locally advanced esophageal cancer, neoadjuvant chemoradiation
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/07d7t1z8
-
4دورية أكاديمية
المؤلفون: Wu, ChunlanAff1, Aff2, Ke, YujunAff3, Aff4, Wan, LuyingAff1, Aff2, Xie, XianheAff1, Aff2, Aff5, IDs0026202403663z_cor4
المصدر: Cancer Immunology, Immunotherapy. 73(5)
-
5دورية أكاديمية
المؤلفون: Mitsunobu Otsuru, Nobuhiro Yamakawa, Tadaaki Kirita, Shin-ichi Yamada, Hiroshi Kurita, Takuma Kugimoto, Hiroyuki Harada, Takumi Hasegawa, Masaya Akashi, Akinori Takeshita, Narikazu Uzawa, Masahiro Umeda, Souichi Yanamoto, Tomohiro Yamada
المصدر: Journal of Dental Sciences, Vol 19, Iss 3, Pp 1628-1637 (2024)
مصطلحات موضوعية: Oral cancer, Immune checkpoint inhibitors (ICIs), Progression-free survival (PFS), PFS 2 (PFS2), Japan, Dentistry, RK1-715
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Jianfen Zhu, Xiaokai Ding, Jianna Zhang, Bo Chen, Xiaohan You, Xinxin Chen, Tianxin Chen
المصدر: BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
مصطلحات موضوعية: Anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF), Immune checkpoint inhibitors (ICIs), Acute kidney injury (AKI)., Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1471-2407
-
7دورية أكاديمية
المؤلفون: Jian Liu, Min Wu, Yifan Yang, Zixuan Wang, Shan He, Xun Tian, Hui Wang
المصدر: Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
مصطلحات موضوعية: γδ T cells, PD-1/PD-L1, Immune checkpoints (ICPs), Tumor microenvironment (TME), Immunosuppressive molecules, Immune checkpoint inhibitors (ICIs), Medicine
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1479-5876
-
8دورية أكاديمية
المؤلفون: Naoko Shigeta, Shuji Murakami, Tomoyuki Yokose, Tetsuya Isaka, Kanako Shinada, Takuya Nagashima, Hiroyuki Adachi, Shunsuke Shigefuku, Kotaro Murakami, Jun Miura, Noritake Kikunishi, Kozue Watabe, Haruhiro Saito, Hiroyuki Ito
المصدر: Thoracic Cancer, Vol 15, Iss 17, Pp 1343-1349 (2024)
مصطلحات موضوعية: immune checkpoint inhibitors (ICIs), non‐small cell lung cancer (NSCLC), PD‐L1 immunohistochemistry assay, programmed death ligand‐1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
9دورية أكاديمية
المؤلفون: Jia-ning Wang, Yue Zhang, Chen-ye Huang, Kang Li, Xiao-bing Yu
المصدر: BMC Ophthalmology, Vol 24, Iss 1, Pp 1-5 (2024)
مصطلحات موضوعية: Immune checkpoint inhibitors (ICIs), Vogt-Koyanagi-Harada disease (VKHD)-like uveitis, Immune-related adverse events (irAEs), Anti-PD-1 (Toripalimab), Ophthalmology, RE1-994
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1471-2415
-
10دورية أكاديمية
المؤلفون: Castillo, Dani, Jeon, Won, Park, Daniel, Pham, Bryan, Yang, Chieh, Joung, Bowon, Moon, Jin, Lee, Jae, Chong, Esther, Park, Kiwon, Reeves, Mark, Duerksen-Hughes, Penelope, Mirshahidi, Hamid, Mirshahidi, Saied
المصدر: International Journal of Molecular Sciences. 24(14)
مصطلحات موضوعية: immune-checkpoint inhibitors (ICIs), interleukin-1 beta (IL-1β), non-small cell lung cancer (NSCLC), programmed death ligand 1 (PD-L1), therapeutic resistance, Humans, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung, Immunotherapy, Lung Neoplasms, Programmed Cell Death 1 Receptor, Tumor Microenvironment, Interleukin-1beta
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/38462105